Related Experiment Video
Updated: Jul 12, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Anti-neurofascin-186 associated combined central and peripheral demyelination (CCPD): A novel entity
Aradhya Sekhar Bagchi1, A Nalini1, M Netravathi1
1Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Introduction:
Combined Central and Peripheral Demyelination (CCPD) is a rare yet a novel entity that is increasingly being recognized in clinical practice all over the world. The etiopathogenesis is largely unknown, but antibodies against paranodal proteins are usually incriminated.
Case Report:
A 28-year-old male patient presented with initial relapsing-remitting followed by progressive neurological deficits. MRI of the Brain and spine revealed lesions typical of MS with multiple cranial and peripheral nerve thickening and enhancement. Nerve conduction study revealed demyelinating sensorimotor polyneuropathy. Anti-Neurofascin antibody panel revealed positive anti-NF140 and anti-NF 186.
Conclusion:
Cases presenting with features suggestive of CNS and PNS demyelination, should be worked up for the presence of anti-neurofascin antibodies along with MRI and electrophysiological studies.
More Related Videos
Related Concept Videos
Diphtheria
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

